Pi-Cardia Archives - Cardiovascular News

First US commercial cases performed with ShortCut leaflet modification device

3rd March 2025

Pi-Cardia has announc...

ShortCut leaflet splitting device gains US FDA market clearance

30th September 2024

The US Food and Drug ...

EuroPCR 2024: Leaflet splitting device may offer efficient option for avoiding coronary obstruction during valve-in-valve procedures

17th May 2024

Insights from the investi...

Pi-Cardia appoints Gary Gratson to lead commercialisation of ShortCut

12th December 2023

Pi-Cardia has appoint...

First US procedure performed using ShortCut leaflet splitting device

20th December 2022

Pi-Cardia has announced t...

Pi-Cardia closes a US$27 million financing round led by Sofinnova Partners

22nd April 2020

Pi-Cardia has closed ...

Leaflex Performer: A non-implant based treatment for aortic stenosis

16th July 2018

Given sufficient time...

EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

18th May 2018

Pi-Cardia has recently st...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy